MINERVAX ApS

CVR32673287

Core data

Name
MINERVAX ApS
Address
Nordre Fasanvej 215, 2000, Frederiksberg
Founded
Jan 14, 2010
Employees (CVR)
28
Locations (P-units)
1View locations
Website
https://minervax.com/
LinkedIn
minervax-aps
Branch
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)

Keep track of MINERVAX ApS

Get an email when we detect changes to financial reports, ownership or management. Save yourself checking the company again.
Free account

Description

MinervaX is developing a vaccine, with its lead candidate AlpN GBS being tested in clinical trials for use in pregnancy or by older people.

Develops vaccines targeting unmet medical needs and advances candidates through clinical trials.

Products & services

AlpN GBS vaccine candidate

Industries

Vaccine development · Biotechnology · Healthcare

Financials

Reporting period
2023EUROpen PDF
Net income
-198,898,000
Total assets
623,542,000
Equity
503,956,000
2018–2023

Unlock financial history

Datapublica Risk Score

Locked
Assesses the risk of financial distress using the company’s accounts, history, and connections.
Company score
0 · Low100 · High

What goes into the assessment

  • Financials

  • Accounts and history

  • Owners and management

  • Company and connections

Standard: Score and risk bandPro: Also a detailed explanation of the factors

Contact

From cvr.dk

From minervax.com

Main
in**@minervax.comShow full
Company
+45 22 11 ** **Show full

Gazelle

Loading gazelle status…

Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.

People

Emmanuelle CoutanceauRoles
Board
TitlesBESTYRELSESMEDLEM
Sten VerlandRoles
Board
TitlesBESTYRELSESMEDLEM
Per Bo Pedersen FischerRoles
Management
TitlesADM. DIR.

Auditor

EY Godkendt RevisionspartnerselskabAuditorChristian Schwenn JohansenRoleState Authorised Public AccountantFromJun 30, 2026
EY Godkendt RevisionspartnerselskabAuditorRasmus Bloch JespersenRoleState Authorised Public AccountantFromJun 30, 2026

Unknown Other Participant

Ownership15–19.99 %Voting rights15 %FromOct 9, 2023
Ownership15–19.99 %Voting rights15 %FromDec 10, 2020

Unknown Other Participant

Ownership10–14.99 %Voting rights10 %FromNov 23, 2022

Unknown Other Participant

Ownership5–9.99 %Voting rights5 %FromOct 25, 2022

Unknown Other Participant

Ownership5–9.99 %Voting rights5 %FromOct 9, 2023

Unknown Other Participant

Ownership5–9.99 %Voting rights5 %FromNov 23, 2022

Unknown Other Participant

Ownership5–9.99 %Voting rights5 %FromNov 23, 2022
Ownership5–9.99 %Voting rights5 %FromOct 25, 2022

Unknown Other Participant

Ownership5–9.99 %Voting rights5 %FromNov 23, 2022
Ownership5–9.99 %Voting rights5 %FromNov 23, 2022

Ultimate owners

🇳🇱LSP 7 Coöperatief U.A.
Ownership through
Direct
15–19.99 %
NOVO NORDISK FONDEN
Ownership through
15–19.99 %
🇬🇧BB Pureos Bioventures, LP
Ownership through
Direct
10–14.99 %
🇰🇾Adjuvant Global Health Technology Fund, L.P.
Ownership through
Direct
5–9.99 %
🇺🇸OrbiMed Private Investments IX, LP
Ownership through
Direct
5–9.99 %
🇳🇱Sanofi Foreign Participations B.V.
Ownership through
Direct
5–9.99 %
🇸🇪Stiftelsen Industrifonden
Ownership through
Direct
5–9.99 %
🇱🇺Trill Impact Ventures Tech 1 S.à rl
Ownership through
Direct
5–9.99 %
🇩🇪Wellington Partners Life Sciences V GmbH & Co. KG
Ownership through
Direct
5–9.99 %
Danmarks Eksport- og Investeringsfond
1.83–5.5 %
🇱🇺European investment fund
1.66–5 %
DI
0.16–0.75 %
Fagligt Fælles Forbund
0.16–0.75 %
DANSK METALARBEJDERFORBUND
0.1–0.38 %
Arbejdsmarkedets Tillægspension
0.06–0.34 %
A.P. MØLLER OG HUSTRU CHASTINE MC-KINNEY MØLLERS FOND TIL ALMENE FORMAAL
0 %
🇺🇸BlackRock, Inc
0 %
DANSK ARBEJDSGIVERFORENING
0 %
HK Danmark
0 %
KL
0 %
Offentligt Ansattes Organisationer
0 %
PFA-FONDEN
0 %
Velliv Foreningen F.M.B.A.
0 %